The multifaceted functions of ribavirin: antiviral, immunomodulator, or both? - Wikidata - awgldk - TriplyDB

The multifaceted functions of ribavirin: antiviral, immunomodulator, or both?

The multifaceted functions of ribavirin: antiviral, immunomodulator, or both?

http://www.wikidata.org/entity/Q43034060

about

Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond Achieving sustained virologic response after interferon-free hepatitis C virus treatment correlates with hepatic interferon gene expression changes independent of cirrhosis.Ribavirin revisited in the era of direct-acting antiviral therapy for hepatitis C virus infection.Effective lethal mutagenesis of influenza virus by three nucleoside analogs.The effect of dietary bovine colostrum on respiratory syncytial virus infection and immune responses following the infection in the mouse.rCNT2 extracellular cysteines, Cys(615) and Cys(649), are important for maturation and sorting to the plasma membrane.Hepatic Pharmacokinetics and Pharmacodynamics With Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir Treatment and Variable Ribavirin Dosage.

P2860

Q29994527-99C8F0EC-BDB7-4BDF-A29A-7FA6E5CDD085 Q37252581-51519C33-EBEC-44FE-B7DD-5A3D39622A63 Q37563692-0BE716B8-3078-4008-9D31-94DA3964F6C3 Q38919847-A453D50D-C631-40C9-8DCF-F5C4FDDEABAE Q41032140-833E6CA5-F012-4406-BACE-7C4F682D3B56 Q45351252-EBB083C3-33ED-47A2-8588-81BADC4DE7F4 Q47567111-811D5B25-01D4-4CA9-A50A-BA2E570CD20D

P2860

The multifaceted functions of ribavirin: antiviral, immunomodulator, or both?

http://www.wikidata.org/entity/Q43034060

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

The multifaceted functions of ribavirin: antiviral, immunomodulator, or both?

@en

The multifaceted functions of ribavirin: antiviral, immunomodulator, or both?

@nl

type

label

The multifaceted functions of ribavirin: antiviral, immunomodulator, or both?

@en

The multifaceted functions of ribavirin: antiviral, immunomodulator, or both?

@nl

prefLabel

The multifaceted functions of ribavirin: antiviral, immunomodulator, or both?

@en

The multifaceted functions of ribavirin: antiviral, immunomodulator, or both?

@nl

P1433

Q43034060-B970B513-FBE0-4C11-90D1-73DDE701E113

P1476

Q43034060-700FB15A-9EF6-4E0B-B1C6-083E14050364

P2093

Q43034060-B1ACBC10-984C-4211-8491-EF787C28417D

P2860

Q43034060-0A485646-0CB1-476E-9AEC-2F630C9DD42D

Q43034060-0F8440D2-763E-4F6C-A5EB-58FD5FA14476

Q43034060-138E6C53-D0CE-499A-B703-4E2893743919

Q43034060-15FA7605-245E-4174-9AE6-D40E9A4DA26F

Q43034060-20BFCC68-4478-4B89-A98F-8D500699D3E9

Q43034060-28DB80C2-8F41-41C1-B17D-B84D1AE26C5B

Q43034060-3C7F2E09-7114-42B9-9B68-925F3B454206

Q43034060-639E561A-F706-4ABC-8F92-5C17B067EC49

Q43034060-7833813E-6EFC-4936-8BF5-69844180966A

Q43034060-7A6E09A3-2BCC-48B2-9134-0AF1289167CF

P304

Q43034060-46C18684-4831-4CAC-9F0E-819427C7E8C7

P31

Q43034060-8678a4bd-6b29-4b3d-af12-5ee7c26b54d7

Q43034060-B1E24928-27C5-42B8-8D0F-F2768386C1C8

P356

Q43034060-B2809A3E-0AC6-4476-BB42-81642C039108

P407

Q43034060-A596FAD0-CC43-4E74-9F16-DA8CED2AB0CF

P433

Q43034060-62AF20D0-1803-4A10-AB2F-B55767D3C295

P478

Q43034060-9144F832-3E64-44F5-A7E9-D2C3FCB27AE1

P50

Q43034060-2BC2DC03-8028-4FC7-8553-CE4FBEF9CC9E

P577

Q43034060-2858C616-B060-4AA9-BAA7-65BF92362549

P698

Q43034060-43BA7F6B-33E1-4824-A954-A541C049A28E

P356

P1433

P1476

The multifaceted functions of ribavirin: antiviral, immunomodulator, or both?

@en

P2093

Mario U Mondelli

http://www.w3.org/2001/XMLSchema#string

P2860

Ribavirin for the treatment of chronic hepatitis C virus infection: a review of the proposed mechanisms of action

Telaprevir for previously untreated chronic hepatitis C virus infection

Sofosbuvir for previously untreated chronic hepatitis C infection

Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection

Boceprevir for untreated chronic HCV genotype 1 infection

Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner

Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial.

Ribavirin exerts differential effects on functions of Cd4+ Th1, Th2, and regulatory T cell clones in hepatitis C.

Efficacy of nucleotide polymerase inhibitor sofosbuvir plus the NS5A inhibitor ledipasvir or the NS5B non-nucleoside inhibitor GS-9669 against HCV genotype 1 infection.

Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial.

P304

1126-1129

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.27186

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-06-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24753082

http://www.w3.org/2001/XMLSchema#string